{"disease":{"id":"severe-covid-19","name":"severe covid 19"},"drugs":{"marketed":[{"drug_id":"bnt162b6-bivalent-original-omi-ba-4-ba-5","indication_name":"COVID-19 prevention in individuals 5 years of age and older with a history of severe allergic reaction (e.g., anaphylaxis) to a previous dose of any COVID-19 vaccine","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BNT162b6 Bivalent (Original/OMI BA.4/BA.5)","generic_name":"bnt162b6-bivalent-original-omi-ba-4-ba-5","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2 spike protein","drug_class":"vaccine","quality_score":47,"revenue":null,"mechanism":""},{"drug_id":"bnt162b6-bivalent-original-omi-ba-4-ba-5","indication_name":"COVID-19 prevention in individuals 12 years of age and older with a history of severe allergic reaction (e.g., anaphylaxis) to a previous dose of any COVID-19 vaccine","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BNT162b6 Bivalent (Original/OMI BA.4/BA.5)","generic_name":"bnt162b6-bivalent-original-omi-ba-4-ba-5","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2 spike protein","drug_class":"vaccine","quality_score":47,"revenue":null,"mechanism":""},{"drug_id":"bnt162b6-bivalent-original-omi-ba-4-ba-5","indication_name":"COVID-19 prevention in individuals 6 months through 4 years of age with a history of severe allergic reaction (e.g., anaphylaxis) to a previous dose of any COVID-19 vaccine","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BNT162b6 Bivalent (Original/OMI BA.4/BA.5)","generic_name":"bnt162b6-bivalent-original-omi-ba-4-ba-5","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2 spike protein","drug_class":"vaccine","quality_score":47,"revenue":null,"mechanism":""},{"drug_id":"part-a-atm-avi-single-dose-cohorts-1-4","indication_name":"Treatment of COVID-19 in adults and pediatric patients (12 years of age and older) who are at high risk of progression to severe COVID-19, including those who are hospitalized due to COVID-19 or who have mild to moderate COVID-19 with at least one risk factor for progression to severe COVID-19 (e.g., older age, certain chronic medical conditions)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Part A: ATM-AVI Single Dose, Cohorts 1-4","generic_name":"part-a-atm-avi-single-dose-cohorts-1-4","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Spike protein of SARS-CoV-2","drug_class":"Monoclonal antibody","quality_score":22,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04505722","title":"A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":44325,"lead_sponsor_name":"Janssen Vaccines & Prevention B.V.","has_results":true},{"nct_id":"NCT04614948","title":"A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":31835,"lead_sponsor_name":"Janssen Vaccines & Prevention B.V.","has_results":true},{"nct_id":"NCT04325646","title":"Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT05543616","title":"A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4292,"lead_sponsor_name":"BioNTech SE","has_results":false},{"nct_id":"NCT04490850","title":"COVID-19 Seroprevalence Study in French Guiana","phase":"NA","overall_status":"COMPLETED","enrollment_count":3541,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT04354779","title":"Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.","phase":"","overall_status":"COMPLETED","enrollment_count":3301,"lead_sponsor_name":"AUVA","has_results":false},{"nct_id":"NCT03831906","title":"Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)","phase":"NA","overall_status":"COMPLETED","enrollment_count":2570,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT05582239","title":"Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults","phase":"","overall_status":"UNKNOWN","enrollment_count":2400,"lead_sponsor_name":"ANRS, Emerging Infectious Diseases","has_results":false},{"nct_id":"NCT05629962","title":"SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2285,"lead_sponsor_name":"Atea Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04648410","title":"Corticosteroids in Severe COVID-19(ASAP-C Study)","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Brno University Hospital","has_results":false},{"nct_id":"NCT04642638","title":"Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":1307,"lead_sponsor_name":"Inovio Pharmaceuticals","has_results":true},{"nct_id":"NCT04644159","title":"Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT04519125","title":"Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":950,"lead_sponsor_name":"Hospital Universitario San Ignacio","has_results":false},{"nct_id":"NCT04732949","title":"Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":623,"lead_sponsor_name":"Synairgen Research Ltd.","has_results":true},{"nct_id":"NCT04402879","title":"CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals","phase":"NA","overall_status":"UNKNOWN","enrollment_count":596,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT06235866","title":"Risk Identification of Long-term Complications","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":500,"lead_sponsor_name":"Wuhan Central Hospital","has_results":false},{"nct_id":"NCT04866082","title":"Corticosteroids in Severe COVID-19 (ASAP-ESICM/ESAIC Study)","phase":"","overall_status":"COMPLETED","enrollment_count":466,"lead_sponsor_name":"Brno University Hospital","has_results":false},{"nct_id":"NCT04649931","title":"Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)","phase":"","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"B. Braun Melsungen AG","has_results":false},{"nct_id":"NCT05254990","title":"Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":414,"lead_sponsor_name":"Dompé Farmaceutici S.p.A","has_results":true},{"nct_id":"NCT04711863","title":"Fluvoxamine for Adults With Mild to Moderate COVID-19","phase":"PHASE2","overall_status":"SUSPENDED","enrollment_count":400,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT04333420","title":"Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":399,"lead_sponsor_name":"InflaRx GmbH","has_results":true},{"nct_id":"NCT04808882","title":"ANTIcoagulation in Severe COVID-19 Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":353,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05596617","title":"Safety and Efficacy of Medications COVID-19","phase":"NA","overall_status":"COMPLETED","enrollment_count":335,"lead_sponsor_name":"Hospital San Carlos, Madrid","has_results":false},{"nct_id":"NCT04681001","title":"Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Marinomed Biotech AG","has_results":false},{"nct_id":"NCT04474340","title":"COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Ministry of Health, Kuwait","has_results":false},{"nct_id":"NCT04924829","title":"Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Hospital Italiano de Buenos Aires","has_results":false},{"nct_id":"NCT05279235","title":"Efficacy and Safety of JT001 (VV116) Compared With Favipiravir","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":290,"lead_sponsor_name":"Shanghai Vinnerna Biosciences Co., Ltd.","has_results":false},{"nct_id":"NCT04449276","title":"A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"CureVac","has_results":true},{"nct_id":"NCT04588363","title":"COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C","phase":"","overall_status":"COMPLETED","enrollment_count":244,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04713176","title":"Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":240,"lead_sponsor_name":"Daewoong Pharmaceutical Co. LTD.","has_results":false},{"nct_id":"NCT05107258","title":"A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care","phase":"","overall_status":"COMPLETED","enrollment_count":195,"lead_sponsor_name":"Pine Trees, Inc.","has_results":false},{"nct_id":"NCT04952519","title":"Efficacy of Amantadine Treatment in COVID-19 Patients","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":193,"lead_sponsor_name":"Noblewell","has_results":false},{"nct_id":"NCT05447013","title":"Generation of SARS-CoV-2-specific T Lymphocytes From Recovered Donors and Administration to High-risk COVID-19 Patients","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":182,"lead_sponsor_name":"George Papanicolaou Hospital","has_results":false},{"nct_id":"NCT06714032","title":"Effect of Traditional Chinese Medicine of Severe COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"Henan University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT04542967","title":"Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Hospital Central Militar","has_results":false},{"nct_id":"NCT04470531","title":"Role of Co-trimoxazole in Severe COVID-19 Patients","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":94,"lead_sponsor_name":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","has_results":false},{"nct_id":"NCT04750278","title":"A Phase 2/3 Study to Evaluate FP-025 in Patients With Severe to Critical COVID 19","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":90,"lead_sponsor_name":"Foresee Pharmaceuticals Co., Ltd.","has_results":true},{"nct_id":"NCT04918901","title":"Comparative Analysis of Clinical Parameters and Radiographic Changes of Severe COVID-19","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05233605","title":"Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation","phase":"","overall_status":"RECRUITING","enrollment_count":72,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05175833","title":"Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Universidade de Passo Fundo","has_results":false},{"nct_id":"NCT04569877","title":"GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"University of Giessen","has_results":false},{"nct_id":"NCT06693362","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT04327505","title":"Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":34,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04715360","title":"Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Hayandra Peduli Foundation","has_results":false},{"nct_id":"NCT04880694","title":"A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Grand Medical Pty Ltd.","has_results":false},{"nct_id":"NCT04935450","title":"Pulmonary Inflammation in COVID-19 ARDS","phase":"","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Hospital Universitario Ramon y Cajal","has_results":false},{"nct_id":"NCT02765191","title":"MR-Evaluation of Renal Function In Septic Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Uppsala University","has_results":false},{"nct_id":"NCT05158842","title":"Treatment of COVID-19 Positive/Negative Bangladeshi Adults With Severe Respiratory Complaints by a Locally Made bCPAP: Feasibility Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"International Centre for Diarrhoeal Disease Research, Bangladesh","has_results":false},{"nct_id":"NCT04320511","title":"Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2","phase":"","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"Corewell Health East","has_results":false},{"nct_id":"NCT04433949","title":"Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":14,"lead_sponsor_name":"Emory University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}